Every Form 4 that Enact Holdings, Inc. (ACT) has filed with the SEC in the last 12 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A Form 4 covers the transactions officers, directors and large holders report, so if you follow ACT and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full ACT filings page.
Enact Holdings, Inc. President and CEO Rohit Gupta reported equity award activity involving Performance Stock Units and common stock. On February 24, 2026, 190,594 Performance Stock Units granted on February 9, 2023 vested and converted into 190,594 shares of common stock on a 1:1 basis. To cover tax withholding obligations from this vesting, 82,795 common shares were withheld at a price of $41.46 per share. After these transactions, Gupta directly owned 518,179 shares of Enact common stock.
Enact Holdings EVP and Chief Risk Officer Michael Derstine reported equity award activity involving Performance Stock Units and common stock. On February 24, 2026, 17,952 Performance Stock Units vested and were exercised into 17,952 shares of common stock at no cost, increasing his direct holdings. On the same date, 5,341 shares of common stock valued at $41.46 per share were withheld by the company to cover tax obligations, leaving him with 48,104 directly owned common shares after these transactions.
Enact Holdings EVP, CFO and Treasurer Mitchell Hardin Dean reported equity compensation activity involving Performance Stock Units and common stock. On February 24, 2026, 42,616 Performance Stock Units granted on February 9, 2023 vested and converted into the same number of Enact common shares on a 1:1 basis.
To cover tax withholding on the vested units, the company withheld 17,723 common shares at $41.46 per share as a tax-withholding disposition. After these transactions, Dean directly owned 142,298 shares of Enact common stock.
Enact Holdings executive reports equity award activity and tax withholding. EVP and General Counsel Evan Stolove exercised 19,072 Performance Stock Units granted on February 9, 2023, which settled into 19,072 shares of common stock on a 1:1 basis on February 24, 2026.
On the same date, 5,851 shares of common stock were disposed of at $41.46 per share to satisfy tax withholding obligations related to the vesting of these Performance Stock Units. After these transactions, Stolove directly owned 52,027 shares of Enact Holdings common stock.
Enact Holdings, Inc. President and CEO Rohit Gupta reported equity award activity involving restricted stock units and common shares. On February 20, 2026, 15,197 restricted stock units were exercised and converted into 15,197 shares of common stock at a price of $0.0000 per share, increasing his directly held common stock to 416,982 shares before tax withholding. The company then withheld 6,602 common shares at $41.4300 per share to cover tax obligations related to restricted stock units that vested based on the February 20, 2026 closing price, leaving 410,380 common shares directly owned. The footnotes state that each restricted stock unit settles into one share of common stock and that these units vest and convert in three equal annual installments beginning on February 21, 2026.
Enact Holdings, Inc. Controller James McMullen reported equity award activity involving restricted stock units and common shares. On February 20, 2026, 690 restricted stock units were exercised or converted into 690 shares of common stock at $0.0000 per share. To cover tax withholding for vested restricted stock units, 233 shares of common stock were disposed of at $41.4300 per share. After these transactions, McMullen directly held 3,772 shares of common stock and 1,379 restricted stock units, each RSU settling into one share of common stock.
Enact Holdings EVP and General Counsel Evan Stolove reported equity compensation activity involving restricted stock units and common shares. On February 20, 2026, 2,029 restricted stock units were exercised and converted into 2,029 shares of Enact common stock at a price of $0.00 per share.
Following this conversion, Stolove directly owned 39,384 common shares before tax withholding. To satisfy tax obligations on the vested restricted stock units, the company withheld 578 common shares at a price of $41.43 per share, leaving Stolove with 38,806 directly owned common shares after these transactions.
Enact Holdings EVP, CFO and Treasurer Mitchell Hardin Dean reported routine equity compensation activity. On February 20, 2026, 5,068 Restricted Stock Units were exercised and converted into 5,068 shares of common stock on a 1:1 basis. To cover tax withholding on vested RSUs, 1,442 common shares were withheld at a price of $41.43 per share, described as a tax-withholding disposition rather than an open-market sale. After these transactions, Dean directly held 117,405 shares of common stock and 10,128 Restricted Stock Units that continue to vest in three equal annual installments beginning on February 21, 2026.
Enact Holdings EVP and Chief Risk Officer Michael Derstine exercised 2,029 Restricted Stock Units that converted into the same number of Enact common shares on February 20, 2026. To cover tax obligations on the vesting, 578 common shares were disposed of at $41.43 per share through share withholding.
Enact Holdings, Inc. executive Brian Gould, EVP & Chief Operations Officer, reported routine equity compensation activity. On February 20, 2026, he exercised 1,623 Restricted Stock Units, which converted on a 1:1 basis into 1,623 shares of common stock. To cover tax withholding for RSUs vesting on February 21, 2026, 462 common shares were withheld at a price of $41.43 per share. After these transactions, he directly held 34,049 shares of common stock and 3,241 Restricted Stock Units, which vest in three equal annual installments beginning on February 21, 2026.
Enact Holdings, Inc. President and CEO Rohit Gupta reported equity compensation activity. On February 13, 2026, he received a grant of 38,092 Restricted Stock Units, which vest and convert to common stock in three equal annual installments beginning on February 13, 2027. On February 17, 2026, he exercised 18,771 RSUs, converting them into the same number of common shares, and then 8,155 common shares were disposed of at $43.29 per share to satisfy tax withholding obligations related to vested RSUs. Following these transactions, he directly owned 401,785 shares of common stock.
Enact Holdings EVP and General Counsel Evan Stolove reported equity compensation activity involving restricted stock units (RSUs) and common stock. On February 13, 2026, he received a grant of 4,876 RSUs, which vest and convert into common stock in three equal annual installments beginning on February 13, 2027. Each RSU settles into one share of Enact common stock.
On February 17, 2026, 2,508 RSUs were exercised and converted into 2,508 shares of common stock, increasing his directly held common stock to 38,069 shares before tax withholding. The company then withheld 714 shares of common stock, valued at $43.29 per share, to satisfy tax withholding obligations related to RSUs that vested on February 16, 2026, leaving him with 37,355 common shares owned directly.
Enact Holdings EVP and Chief Risk Officer Michael Derstine reported several equity award transactions. On February 13, 2026, he received a grant of 6,826 Restricted Stock Units (RSUs), each settling into one share of Enact common stock, vesting in three equal annual installments beginning on February 13, 2027.
On February 17, 2026, 2,508 RSUs were exercised and converted into 2,508 shares of common stock at a stated price of $0.0000 per share, reflecting a non-cash derivative conversion. The related RSU balance decreased to 2,498 units, while common stock holdings increased to 34,754 shares before tax withholding.
To cover tax obligations for vested RSUs, the company withheld 712 shares of common stock at a price of $43.2900 per share, leaving Derstine with 34,042 common shares held directly after these transactions. Footnotes state that certain RSU awards vest and convert to common stock in three equal annual installments beginning on February 16, 2025 and February 13, 2027.
Enact Holdings EVP & Chief Operations Officer Brian Gould reported multiple equity award transactions. He received a grant of 3,901 Restricted Stock Units that vest in three equal annual installments beginning on February 13, 2027. On February 17, 2,009 RSUs were exercised into 2,009 shares of common stock, and 595 shares of common stock were withheld at $43.29 per share to cover tax obligations on vested RSUs. After these transactions, he directly owned 32,888 shares of common stock and 5,898 RSUs in total.
Enact Holdings, Inc. executive Mitchell Hardin Dean, EVP, CFO and Treasurer, reported equity compensation transactions involving restricted stock units (RSUs) and common stock. On February 13, 2026, he received a grant of 13,165 RSUs, each settling into one share of common stock and vesting in three equal annual installments beginning February 13, 2027.
On February 17, 2026, 6,262 RSUs were exercised and converted into 6,262 shares of common stock at no cost, while 1,781 shares of common stock were withheld at $43.29 per share to cover tax obligations for RSUs that vested on February 16, 2026.
Enact Holdings, Inc. Controller James McMullen reported multiple equity-related transactions. On February 13, 2026, he received a grant of 1,707 Restricted Stock Units (RSUs), which, according to the terms, vest and convert into common stock in three equal annual installments beginning on February 13, 2027.
On February 17, 2026, 820 RSUs were exercised or converted into 820 shares of common stock at a price of $0.00 per share, reflecting a derivative exercise. The filing also shows a disposition of 277 shares of common stock at $43.29 per share to satisfy tax withholding obligations tied to RSUs that vested on February 16, 2026.
After these transactions, McMullen directly holds 3,315 shares of common stock and retains 1,707 RSUs from the new grant, each settling into one share of common stock on a 1:1 basis as they vest.
Enact Holdings, Inc. director Robert P. Restrepo Jr. reported an open-market sale of common stock. On February 11, 2026, he sold 5,000 shares of Enact Holdings common stock at a price of $42.95 per share through a series of broker-assisted transactions, with all sales at that price.
Following this transaction, the filing states that he beneficially owns 0 shares of Enact Holdings common stock in direct ownership form.
Enact Holdings executive Evan Stolove, EVP, General Counsel & Secretary, reported equity compensation activity involving restricted stock units and common stock. On February 9, 2026, 3,170 restricted stock units converted into 3,170 shares of common stock on a 1:1 basis. To cover tax withholding on these vested units, the company withheld 1,070 shares of common stock at a price of $42.39 per share. After these transactions, Stolove directly owned 35,561 shares of Enact Holdings common stock.
Enact Holdings, Inc. executive Mitchell Hardin Dean, EVP, CFO and Treasurer, reported the vesting of restricted stock units and related share movements. On February 9, 2026, 7,095 restricted stock units were converted into an equal number of shares of common stock, increasing his direct holdings to 111,470 shares.
On the same date, 2,172 shares of common stock were withheld by the company at a price of $42.39 per share to satisfy tax withholding obligations tied to this vesting, leaving Dean with 109,298 shares of common stock held directly after the transactions.
Enact Holdings EVP & Chief Operations Officer Brian Gould reported equity award activity involving company stock. On February 9, 2026, Gould exercised or converted 2,609 restricted stock units into the same number of Enact common shares, reflecting the 1:1 settlement terms of the award.
On the same day, 881 common shares were disposed of at $42.39 per share to cover tax withholding obligations related to the vesting. After these transactions, Gould directly beneficially owned 31,474 shares of Enact common stock.
Enact Holdings executive Michael Derstine, EVP and Chief Risk Officer, reported equity award activity on February 9, 2026. He exercised or converted 2,981 restricted stock units into the same number of Enact common shares. The company then withheld 1,006 common shares at $42.39 to cover taxes, leaving Derstine with 32,246 shares of common stock held directly after these transactions.
Enact Holdings, Inc. President and CEO Rohit Gupta reported equity compensation activity. On February 9, 2026, 31,762 restricted stock units converted into the same number of Enact common shares, a non-cash derivative exercise. The company then withheld 10,348 shares at $42.39 per share to cover related tax obligations. After these transactions, Gupta directly owned 391,169 shares of Enact common stock.
Enact Holdings, Inc. controller James McMullen reported equity compensation activity involving restricted stock units and common stock. On February 9, 2026, 967 restricted stock units converted into 967 shares of common stock on a 1:1 basis, increasing his directly held common stock to 3,099 shares.
The company then withheld 327 shares of common stock at a price of $42.39 per share to cover tax obligations related to the vesting, reducing his directly held balance to 2,772 shares. The restricted stock units vest and convert to common stock in three equal annual installments beginning on February 9, 2024.
Genworth Holdings, Inc., a major shareholder of Enact Holdings, Inc., reported selling 634,953 shares of Enact common stock on January 30, 2026. The sale was made to Enact under a previously signed Share Repurchase Agreement at a price of $39.3661 per share.
After this transaction, Genworth Holdings beneficially owns 114,588,830 Enact common shares, which represents approximately 81% of Enact’s outstanding common stock. The transaction reflects an internal share repurchase arrangement rather than an open-market sale to third-party investors.
Enact Holdings, Inc. reported that one of its directors acquired 165 deferred stock units on December 11, 2025 through reinvestment of a cash dividend paid at $0.21 per share.
These deferred stock units become payable in shares of common stock one year after the director’s service as a director ends. After this transaction, the director beneficially owns 30,543.457 deferred stock units, held directly and recorded at a price of $0 per unit.
Enact Holdings, Inc. reported that one of its directors acquired 165 deferred stock units on December 11, 2025 through dividend reinvestment at $0.21 per share. These deferred stock units will be paid out in shares of common stock one year after the director’s board service ends.
After this transaction, the director beneficially owns 30,543.457 deferred stock units, held directly.
Enact Holdings, Inc. reported that one of its officers, serving as Controller, acquired additional restricted stock units (RSUs) tied to existing equity awards. The RSUs were credited on December 11, 2025 under dividend reinvestment terms connected to a quarterly cash dividend of $0.21 per share.
Each restricted stock unit is structured to settle into one share of common stock on a 1:1 basis. The affected RSU awards vest and convert to common stock in three equal annual installments, with different grants beginning on February 9, 2024, February 16, 2025, April 1, 2025, February 21, 2026, and October 1, 2026. The transactions were reported as acquisitions at a $0 exercise price, reflecting their nature as stock-based compensation rather than open-market purchases.
Enact Holdings, Inc. reported that an officer serving as EVP and Chief Risk Officer acquired additional restricted stock units on December 11, 2025. The filing shows three small additions of 16, 27 and 33 restricted stock units, each settling into one share of common stock and credited at a price of $0 under existing awards.
Footnotes explain that these extra units were issued under dividend reinvestment terms following a quarterly cash dividend of $0.21 per share paid on December 11, 2025. The related restricted stock unit awards vest in three equal annual installments beginning on February 9, 2024, February 16, 2025 and February 21, 2026.
Enact Holdings, Inc. reported an insider equity change involving one of its directors. On December 11, 2025, the director acquired 31 deferred stock units through dividend reinvestment tied to a $0.21 per share dividend. These deferred stock units are payable in shares of common stock one year after the director’s service ends. Following this transaction, the director beneficially owns 5,688.256 deferred stock units.
Enact Holdings, Inc. reported an equity award update for its EVP & Chief Operations Officer. On December 11, 2025, the officer acquired 14, 22 and 26 restricted stock units at $0 per unit under dividend reinvestment terms tied to a quarterly dividend of $0.21 per share paid on that date.
Each restricted stock unit will settle into one share of Enact common stock. The underlying grants vest and convert to common stock in three equal annual installments beginning on February 9, 2024, February 16, 2025 and February 21, 2026, respectively. After these transactions, reported restricted stock unit holdings for the three grants were 2,609, 4,006 and 4,864 units, all held directly.
Enact Holdings, Inc. disclosed that one of its directors acquired 142 deferred stock units on December 11, 2025. These deferred stock units are linked to Enact’s common stock and will be paid out in shares one year after the director’s service on the board ends.
The 142 additional units were credited under a director award agreement through dividend reinvestment from a cash dividend paid on December 11, 2025 at $0.21 per share. After this transaction, the director beneficially owns 26,492.538 deferred stock units, held directly.
Enact Holdings, Inc.'s President and CEO, who also serves as a director, received additional restricted stock units as part of existing equity awards tied to the company’s quarterly dividend.
On December 11, 2025, three groups of restricted stock units were credited in amounts of 169, 200 and 243 units, all at a price of $0, increasing the executive’s direct holdings in these awards to 31,762, 37,533 and 45,583 units, respectively. Each restricted stock unit will settle into one share of common stock when it vests.
The related awards vest in three equal annual installments, beginning on February 9, 2024, February 16, 2025 and February 21, 2026. The extra units were acquired under reinvestment terms in the award agreements, based on a quarterly dividend of $0.21 per share paid on December 11, 2025.
Enact Holdings, Inc. reported an insider equity award for one of its directors. On December 11, 2025, the director acquired 165 deferred stock units tied to Enact common stock. These units were credited at a price of $0 per unit under the director award agreement from a cash dividend paid at $0.21 per share on the same date. Following this transaction, the director beneficially owns 30,543.457 deferred stock units, which become payable in shares of common stock one year after the director’s termination of service.
Enact Holdings, Inc. reported that a director and chairperson of the board acquired additional deferred stock units linked to its common stock. On 12/11/2025, 289 deferred stock units were acquired at a price of $0.00 per unit under reinvestment terms tied to a dividend paid on that date at $0.21 per share.
After this transaction, the reporting person beneficially owns 9,012.163 deferred stock units directly. Additional deferred stock units are held indirectly, including 24,177 units through the Deborah Addesso Exempt Irrevocable Trust f/b/o Dominic dated December 28, 2021 and 20,650 units through D.J. Addesso Holdings, LLC. These deferred stock units become payable in shares of common stock one year after termination of service as a director.
Enact Holdings, Inc. disclosed that an officer serving as EVP, CFO and Treasurer acquired additional restricted stock units on December 11, 2025 through dividend reinvestment features in existing awards. On that date, the officer received 38, 67 and 81 restricted stock units at a price of $0.00 each, tied to a quarterly dividend of $0.21 per share paid on December 11, 2025.
Each restricted stock unit will settle into one share of Enact common stock. The related awards vest and convert to common stock in three equal annual installments beginning on February 9, 2024, February 16, 2025 and February 21, 2026. Following these transactions, the officer beneficially owned 7,095, 12,512 and 15,196 restricted stock units across the respective grants.
Enact Holdings, Inc. reported an insider equity transaction by its EVP, General Counsel & Secretary. On December 11, 2025, the executive acquired additional restricted stock units (RSUs) in three separate awards of 17, 27, and 33 units, all at a price of $0 per unit.
Each RSU will settle into one share of Enact common stock. The filing explains that these extra RSUs were credited under the award agreements’ reinvestment terms based on a quarterly dividend of $0.21 per share paid on December 11, 2025. The related RSU awards vest in three equal annual installments beginning on February 9, 2024, February 16, 2025, and February 21, 2026, and the executive now directly holds 3,170, 5,006, and 6,080 RSUs under these grants.
Enact Holdings, Inc. reported an insider equity transaction involving deferred stock units for one of its directors. On December 11, 2025, the director acquired 165 deferred stock units linked to Enact common stock.
The award arose from dividend reinvestment under the director award agreement, based on a dividend of $0.21 per share paid on that date. Following this transaction, the director beneficially owns 30,543.457 deferred stock units.
Enact Holdings, Inc. reported an insider transaction by a director involving deferred stock units linked to company dividends. On 12/11/2025, the director acquired 165 deferred stock units under a director award agreement through reinvestment of a cash dividend paid at $0.21 per share.
Following this transaction, the director beneficially owns a total of 30,543.457 deferred stock units on a direct basis. These deferred stock units become payable in shares of Enact Holdings common stock one year after the director’s service on the board ends.
Enact Holdings, Inc. (ACT) disclosed a Form 4 showing that a company director sold Enact common stock in two transactions. On 11/18/2025, the director sold 2,562 shares of common stock at a weighted average price of $37.411 per share as part of a series of broker-assisted sales ranging from $37.39 to $37.44 per share. On 11/19/2025, the director sold an additional 7,438 shares at $37.39 per share. After these sales, the director reported owning 5,000 shares of Enact common stock directly.
Genworth Holdings, Inc. reported the sale of 940,819 shares of Enact Holdings, Inc. common stock on 10/31/2025 at $36.1934 per share. The transaction was effected pursuant to a Share Repurchase Agreement dated April 30, 2025.
Following the sale, Genworth beneficially owns 117,010,462 Enact shares and is identified as a Director and 10% Owner. The filing notes Genworth owns approximately 81% of Enact’s outstanding common stock.
Enact Holdings insider James McMullen reported a grant of 2,599 Restricted Stock Units (RSUs) on 10/01/2025. Each RSU converts 1:1 into common stock and carries a $0 purchase price; after the grant he beneficially owns 2,599 shares directly. The RSUs vest in three equal annual installments beginning 10/01/2026, so the first conversion to shares is scheduled one year after the grant. The filing was signed under power of attorney on 10/03/2025.
Genworth Holdings, Inc. reported the sale of 922,169 shares of Enact Holdings, Inc. (ACT) common stock on 09/30/2025 at a price of $38.3466 per share. The filing states the transaction was effected under a Share Repurchase Agreement dated April 30, 2025, and the per-share price reflects a weighted average price paid by the issuer for third-party purchases under that agreement. After the reported sale, Genworth Holdings beneficially owned 117,951,281 shares, which the filing says represents approximately 81% ownership of Enact outstanding common stock.